Reata Pharmaceuticals, Inc. Stock
Equities
RETA
US75615P1030
Biotechnology & Medical Research
Latest transcript on Reata Pharmaceuticals, Inc.
Managers | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director of Finance/CFO | 60 | 23-09-25 | |
John Hunter
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
J. Huff
CEO | Chief Executive Officer | 70 | 22-08-31 |
Director/Board Member | - | 23-09-25 | |
Michael Dambach
BRD | Director/Board Member | - | 23-09-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.10% | 0 M€ | 0.00% | - | |
0.07% | 0 M€ | 0.00% | - | |
0.05% | 773 M€ | -.--% | - | |
0.04% | 509 M€ | -.--% |
1st Jan change | Capi. | |
---|---|---|
-3.30% | 102B | |
+1.79% | 96.07B | |
-2.30% | 21.66B | |
-18.35% | 20.77B | |
-8.14% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |